Subject: RXMD Announces Solid Numbers Once Again

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Announces Solid Numbers Once Again
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.06

Change (%): + 0.0018 (3.09)

Volume: 232,311
RXMD Chart

Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018

MIAMI, July 17, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in both revenue and number of prescriptions filled for June 2018.

Progressive Care’s wholly owned subsidiary PharmCo, LLC has seen an 18.75% increase in prescriptions filled over the same month last year, totaling approximately 22,500 prescriptions.

June brought a total revenue of roughly $65 million in net revenues, a slight decrease from last year in the same month. This is due to reimbursement compression and insurance coverage contraction. Insurance carriers have significantly compressed reimbursement rates, especially regarding compounded medications. In addition to decreasing reimbursement rates, many medications (pain treatment alternatives in particular) have been removed from formularies leading to medications not being covered in their entirety or covered for severely restricted doses. However, increasing numbers of filled prescriptions serve as a strong indication of growth among Progressive Care’s core services.

“This year has been momentous for Progressive Care. We anticipated many of the current industry trends and devoted efforts to ensure revenue diversification and service innovation to promote company longevity,” said S. Parikh Mars, CEO of Progressive Care. “Our new DischargeRx program, adherence packaging, and 340B suite of services are already generating avenues for revenue generation. As we continue to develop new products and services, we will also keep advocating for patients whose needs are more complex and who are negatively impacted by coverage contraction.”

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks